Arvinas Reopens $25,000 Researcher Award Competition
The program supports early-career academics driving innovation in targeted protein degradation through the end of 2026.
Updated on Oct. 27, 2026 in Biotech
Live Poll
Do you believe private industry research awards effectively encourage valuable scientific innovation?
Arvinas has reopened its Early Career Researcher Award competition for academics. The program offers a $25,000 prize to graduate students and postdoctoral researchers contributing to targeted protein degradation.
Why it matters
This award supports emerging researchers in the field of targeted protein degradation, a modality that uses the body's natural cellular machinery to eliminate disease-causing proteins.
The award recognizes novel discoveries in targeted protein degradation, a technique that leverages the ubiquitin-proteasome system to tag and destroy specific pathogenic proteins. The $25,000 grant serves to fund early-stage research or professional development for scholars.
The players
Arvinas
A New Haven-based biotechnology company focused on developing therapies through targeted protein degradation and PROTAC protein degrader technology.
The details
Targeted protein degradation uses small molecules to hijack the cell's ubiquitin-proteasome system—a biological pathway that marks misfolded or damaged proteins for destruction. By redirecting this system to target disease-linked proteins, researchers can achieve therapeutic effects unreachable by traditional protein-binding inhibitors. The competition evaluates applicants based on their novel discoveries and scientific leadership within this specific molecular mechanism.
Timeline
Nominations open on November 1, 2026.
Nominations close on December 31, 2026.
The award winner will be recognized in mid-2027.
The Tech Race
This award aligns with the broader industry effort to accelerate innovation in targeted protein degradation, a field currently characterized by intense competition between biotech firms. By incentivizing academic research, Arvinas seeks to maintain its position at the forefront of protein-based therapeutic development.
Graduate students and postdoctoral researchers in academia are eligible to submit nominations for the prize starting in November. This award provides financial support for early-career scientists to advance novel discoveries in the protein degradation field.
The takeaway
The competition highlights the industry's focus on nurturing talent in protein-based therapeutics. Interested researchers should monitor the Arvinas portal to ensure submission before the December 31, 2026 deadline.
What happens next
Nominations must be submitted by the December 31, 2026 deadline to be eligible for the award.
Further reading
For more on the current landscape of protein-focused science, visit our Biotech section.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you believe private industry research awards effectively encourage valuable scientific innovation?
